Art
J-GLOBAL ID:202202253940449475   Reference number:22A1024289

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C

免疫優性Listeriaエピトープに対するT細胞応答は,結腸直腸癌抗原,グアニリルシクラーゼCに対するワクチン指向反応を制限する【JST・京大機械翻訳】
Author (10):
Material:
Volume: 13  Page: 855759  Publication year: 2022 
JST Material Number: U7074A  ISSN: 1664-3224  Document type: Article
Article type: 原著論文  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
The Gram-positive bacterium Li...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1024289&from=J-GLOBAL&jstjournalNo=U7074A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Basic research of immunotherapeutic agents and blood preparations  ,  Tumor immunity 
Reference (67):
  • Emens LA, Ascierto PA, Darcy PK, Demaria S, Eggermont AMM, Redmond WL, et al. Cancer Immunotherapy: Opportunities and Challenges in the Rapidly Evolving Clinical Landscape. Eur J Cancer (2017) 81:116-29. doi: doi: 10.1016/j.ejca.2017.01.035
  • Hunter P. The Fourth Pillar: Despite Some Setbacks in the Clinic, Immunotherapy has Made Notable Progress Toward Becoming an Additional Therapeutic Option Against Cancer. EMBO Rep (2017) 18:1889-92. doi: doi: 10.15252/embr.201745172
  • Popovic A, Jaffee EM, Zaidi N. Emerging Strategies for Combination Checkpoint Modulators in Cancer Immunotherapy. J Clin Invest (2018) 128:3209-18. doi: doi: 10.1172/JCI120775
  • Curran MA, Glisson BS. New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation. Annu Rev Med (2019) 70:409-24. doi: doi: 10.1146/annurev-med-050217-121900
  • Zemek RM, De Jong E, Chin WL, Schuster IS, Fear VS, Casey TH, et al. Sensitization to Immune Checkpoint Blockade Through Activation of a STAT1/NK Axis in the Tumor Microenvironment. Sci Transl Med (2019) 11:eaav7816. doi: doi: 10.1126/scitranslmed.aav7816
more...

Return to Previous Page